Abstract
We explored the prophylactic efficacies of two novel protease inhibitors in murine cysticercosis. Our results demonstrated a 95% and 80% reduction in parasite burden for mice injected with Z-LLL-FMK and Z-LLY-FMK, respectively. Further studies are merited on the role of cysteine proteinase inhibitors in treatment of cysticercosis.
Original language | English (US) |
---|---|
Pages (from-to) | 2886-2888 |
Number of pages | 3 |
Journal | Antimicrobial agents and chemotherapy |
Volume | 50 |
Issue number | 8 |
DOIs | |
State | Published - Aug 2006 |
Externally published | Yes |
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases